Valuation: Codexis, Inc.

Market Cap 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 149.46Cr 58Cr 731.9Cr 56Cr 55Cr 2.35TCr P/E 2026 *
-3.58x
P/E 2027 * -4.66x
Enterprise Value 15Cr 13Cr 12Cr 11Cr 21Cr 1.43TCr 21Cr 149.46Cr 58Cr 731.9Cr 56Cr 55Cr 2.35TCr EV / Sales 2026 *
2.02x
EV / Sales 2027 * 1.7x
Free-Float
92.88%
Yield 2026 *
-
Yield 2027 * -
1 week+3.03%
Current month-2.16%
1 month-4.23%
3 months-44.94%
6 months-25.27%
Current year-16.56%
1 week 1.31
Extreme 1.3091
1.41
1 month 1.27
Extreme 1.27
1.5
Current year 0.96
Extreme 0.9583
2.98
1 year 0.96
Extreme 0.9583
2.98
3 years 0.96
Extreme 0.9583
6.08
5 years 0.96
Extreme 0.9583
42.01
10 years 0.96
Extreme 0.9583
42.01
Manager TitleAgeSince
Chief Executive Officer 59 07/11/2025
Director of Finance/CFO 59 30/09/2024
Chief Tech/Sci/R&D Officer 56 05/05/2020
Director TitleAgeSince
Director/Board Member 66 01/03/2016
Director/Board Member 59 07/11/2025
Chairman 66 -
Date Insider Type Main position Quantity % Market Cap. Importance
23/02/26 Free

Chief Financial Officer

3,16,100 0.3500%
23/02/26 Sell

Chief Technology Officer

3,21,962 0.3565%
23/02/26 Free

Chief Executive Officer

9,93,000 1.0994%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+3.03%-46.46%-31.66% 15Cr
+4.16%+3.04%+49.37%+94.17% 7.42TCr
-3.11%-3.53%+20.19%+81.44% 5.74TCr
+0.89%-0.63%+2.17%+36.19% 4.76TCr
+0.36%+0.81%+342.39%+742.40% 4.43TCr
-0.96%-4.50%+24.96%+35.38% 4.25TCr
-0.20%-0.77%+4.13%+105.50% 4.07TCr
-0.54%+2.93%+9.31%+50.41% 3.1TCr
-2.68%+2.92%+29.33%+22.72% 2.85TCr
+0.05%-1.64%-8.14%-11.37% 2.43TCr
Average -0.20%-0.60%+42.73%+112.52% 3.91TCr
Weighted average by Cap. +0.12%-0.84%+56.92%+138.19%

Financials

2026 *2027 *
Net sales 7.39Cr 6.56Cr 6.13Cr 5.58Cr 11Cr 710.26Cr 11Cr 74Cr 29Cr 363.09Cr 28Cr 27Cr 1.17TCr 8.77Cr 7.79Cr 7.27Cr 6.63Cr 13Cr 842.97Cr 13Cr 88Cr 34Cr 430.94Cr 33Cr 32Cr 1.38TCr
Net income -3.72Cr -3.3Cr -3.08Cr -2.81Cr -5.3Cr -357.48Cr -5.35Cr -37Cr -14Cr -182.75Cr -14Cr -14Cr -586.51Cr -2.97Cr -2.64Cr -2.46Cr -2.24Cr -4.23Cr -285.24Cr -4.27Cr -30Cr -12Cr -145.82Cr -11Cr -11Cr -467.99Cr
Net Debt - -
Logo Codexis, Inc.
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.
Employees
146
Date Price Change Volume
02/26/02 $1.360 0.00% 5,51,872
01/26/01 $1.360 -2.16% 7,52,102
30/26/30 $1.390 +2.96% 9,09,825
29/26/29 $1.350 -0.74% 6,06,563
28/26/28 $1.360 +3.03% 6,99,207
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1.360USD
Average target price
6.143USD
Spread / Average Target
+351.68%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CDXS Stock